Symptom dimensions of post-myocardial infarction depression, disease severity and cardiac prognosis

E J Martens1, P W Hoen, M Mittelhaeuser

  • 1Department of Medical Psychology, Center of Research on Psychology in Somatic Diseases, Tilburg University, The Netherlands. e.j.martens@uvt.nl

Psychological Medicine
|August 21, 2009
PubMed

Insights

Post-myocardial infarction (MI) depression symptoms matter for heart health. Somatic/affective symptoms, unlike cognitive/affective ones, predict worse cardiac outcomes and MI severity.

Area of Science:

  • Cardiology
  • Psychiatry
  • Clinical Psychology

Background:

  • Depression following myocardial infarction (MI) can impact cardiovascular prognosis.
  • Previous research suggests a differential impact of depressive symptom dimensions on cardiac outcomes.
  • Somatic/affective symptoms may be linked to a worse prognosis compared to cognitive/affective symptoms.

Purpose of the Study:

  • To investigate the relationship between specific depressive symptom dimensions after MI and disease severity.
  • To examine the association between depressive symptom dimensions and prospective cardiac prognosis.
  • To validate previous findings on the prognostic value of different depression symptom clusters.

Main Methods:

  • 473 patients admitted for acute MI completed the Beck Depression Inventory (BDI) within the first week.
  • Depressive symptom dimensions were analyzed in relation to baseline left ventricular ejection fraction (LVEF).
  • Prospective cardiac death and/or recurrent MI were tracked over an average follow-up of 2.8 years.

Main Results:

  • Factor analysis identified two key dimensions: somatic/affective and cognitive/affective symptoms.
  • Somatic/affective symptoms were significantly associated with lower LVEF and increased risk of cardiac death/recurrent MI.
  • After controlling for prior MI and LVEF, somatic/affective symptoms remained a significant predictor of adverse cardiac events (HR 1.31).

Conclusions:

  • The study confirms that somatic/affective depressive symptoms, not cognitive/affective, are linked to MI severity and poorer cardiovascular prognosis.
  • Findings underscore the importance of targeting somatic aspects of depression in treatment strategies.
  • Interventions aimed at improving cardiovascular outcomes post-MI should consider the specific symptom profile of depression.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Angina III: Clinical Manifestations and Assessment01:29

Angina III: Clinical Manifestations and Assessment

Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...